Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laser Therapy to Target Fat Tissue

By HospiMedica staff writers
Posted on 05 Jun 2006
New studies on fat-seeking lasers shows that free-electron lasers (FELs) can preferentially heat fat tissues in the body without harming the overlying skin.

Researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital, Harvard Medical School (Boston, MA, USA), and the U.S. More...
Department of Energy's Thomas Jefferson National Accelerator Facility (Jefferson Lab, Newport News, VA, USA) tested human fat obtained from surgically discarded normal tissue and found three wavelengths--915, 1210, and 1720 nm --where fat was more efficiently heated than water. The researchers then exposed fresh, intact pig skin-and-fat tissue samples about two inches thick to FEL infrared light, centered around the two most promising wavelengths, 1210 and 1720 nm.

The researchers zapped the samples with beams of infrared laser light ranging from 8-17 mm wide for about 16 seconds. They found that the 1210 nm wavelength preferentially heated pig fat up to1 cm deep without damaging the overlying skin. The results were presented at the annual meeting of the American Society for Laser Medicine and Surgery in Boston (MA, USA) in April 2006.

"We can envision a fat-seeking laser, and we're heading down that path now,” said Dr. Rox Anderson, lead author on the study and a practicing dermatologist at Harvard. Dr. Anderson is most excited about the potential for using lasers to target sebaceous glands in treating severe acne, but predicts that laser treatments could emerge for other medical conditions involving lipid-rich tissues, such as treatments for atherosclerotic plaque and unwanted cellulite.

"The superconducting radiofrequency accelerator technology that the FEL is built on allows us to tune laser light through a wide range of frequencies, including the infrared, terahertz, and soon, ultraviolet. Traditional lasers don't have that capability; they can only provide light at one frequency,” explained Fred Dylla, FEL project manager at Jefferson Lab.



Related Links:
Wellman Center for Photomedicine
Thomas Jefferson national accelerator facility

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.